Orlifit™

  • All Products
  • By Generic
  • By Therapeutic Segment

Orlifit™

Therapeutic Segment: Anti-Obesity

Generic Name: Orlistat

Indication:

Indicated for:
• Dietary modification (reduced calorie diet) in the management of obesity, i.e. in patients with a BMI of 30Kg/m2 or greater
• Overweight patients with BMI of 27Kg/m2 or more with associated risk factors e.g., (hypertension, diabetes, dyslipidemia).

Available as:

Capsule
  • 120MG